George C. Wang

George C. Wang

Auto-generated profile, based on publicly available information

George C. Wang

Johns Hopkins University School of Medicine

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2012 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
GWGeorge C. Wang
George C. Wang
PDPradyot Dash
Pradyot Dash
JMJonathan A. McCullers
Jonathan A. McCullers
PDPeter C. Doherty
Peter C. Doherty
PTPaul G Thomas
Paul G Thomas
CD8 + T cell diversity may be more important than T cell abundance in limiting the negative consequences of cytomegalovirus persistence.

16 April 2010 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
GWGeorge C. Wang
George C. Wang
WKWen Hong L. Kao
Wen Hong L. Kao
PMPeter Murakami
Peter Murakami
QXQian-Li Xue
Qian-Li Xue
RCRoger B. Chiou
Roger B. Chiou
LFLinda P. Fried
Linda P. Fried
Cytomegalovirus (CMV), a prevalent pathogen, causes severe disease in immunocompromised humans. However, present understanding is limited regarding the long-term clinical effect of persistent CMV infection in immunocompetent adults. The authors conducted a prospective observational cohort study (1992–2002) of 635 community-dwelling women in Baltimore, Maryland, aged 70–79 years in the Women's Health and Aging Studies to examine the effect of CMV infection on the risk of frailty, a common geriatric syndrome, and mortality in older women. The effect of baseline serum CMV antibody (immunoglobulin G) concentration on the risk of 3-year incident frailty, defined by using a 5-component measure, and 5-year mortality was examined with Cox proportional hazards models. Compared with those who were CMV seronegative, women in the highest quartile of CMV antibody concentration had a greater incidence of frailty (hazard ratio = 3.46, 95% confidence interval: 1.45, 8.27) and mortality (hazard ratio = 3.81, 95% confidence interval: 1.64, 8.83). After adjustment for potential confounders, CMV antibody concentration in the highest quartile independently increased the risk of 5-year mortality (hazard ratio = 2.79, 95% confidence interval: 1.22, 6.40). Better understanding of the long-term clinical consequences of CMV infection in immunocompetent humans is needed to guide public health efforts for this widely prevalent infection.

31 October 2012 in Immunity & Ageing
Verified
Journal Article
Open access
PDF file
Rafael SolanaRafael Solana
Rafael Solana
Raquel TarazonaRaquel Tarazona
Raquel Tarazona
AAAllison E Aiello
Allison E Aiello
AAArne N Akbar
Arne N Akbar
VAVictor Appay
Victor Appay
Graham PawelecGraham Pawelec
Graham Pawelec
Alone among herpesviruses, persistent Cytomegalovirus (CMV) markedly alters the numbers and proportions of peripheral immune cells in infected-vs-uninfected people. Because the rate of CMV infection increases with age in most countries, it has been suggested that it drives or at least exacerbates “immunosenescence”. This contention remains controversial and was the primary subject of the Third International Workshop on CMV & Immunosenescence which was held in Cordoba, Spain, 15-16th March, 2012. Discussions focused on several main themes including the effects of CMV on adaptive immunity and immunosenescence, characterization of CMV-specific T cells, impact of CMV infection and ageing on innate immunity, and finally, most important, the clinical implications of immunosenescence and CMV infection. Here we summarize the major findings of this workshop.

8 November 2018 in Immunity & Ageing
Verified
Journal Article
Open access
PDF file
YCYen-Ling Chiu
Yen-Ling Chiu
KSKai-Hsiang Shu
Kai-Hsiang Shu
FYFeng-Jung Yang
Feng-Jung Yang
TCTzu-Ying Chou
Tzu-Ying Chou
PCPing-Min Chen
Ping-Min Chen
YCYi-Fang Chuang
Yi-Fang Chuang
Patients with end-stage renal disease (ESRD) exhibit a premature aging phenotype of the immune system. Nevertheless, the etiology and impact of these changes in ESRD patients remain unknown. Compared to healthy individuals, ESRD patients exhibit accelerated immunosenescence in both T cell and monocyte compartments, characterized by a dramatic reduction in naïve CD4+ and CD8+ T cell numbers but increase in CD8+ TEMRA cell and proinflammatory monocyte numbers. Notably, within ESRD patients, aging-related immune changes positively correlated not only with increasing age but also with longer dialysis vintage. In multivariable-adjusted logistic regression models, the combination of high terminally differentiated CD8+ T cell level and high intermediate monocyte level, as a composite predictive immunophenotype, was independently associated with prevalent coronary artery disease as well as cardiovascular disease, after adjustment for age, sex, systemic inflammation and presence of diabetes. Levels of terminally differentiated CD8+ T cells also positively correlated with the level of uremic toxin p-cresyl sulfate. Aging-associated adaptive and innate immune changes are aggravated in ESRD and are associated with cardiovascular diseases. For the first time, our study demonstrates the potential link between immunosenescence in ESRD and duration of exposure to the uremic milieu.

18 January 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YCYen-Ling Chiu
Yen-Ling Chiu
CLChung-Hao Lin
Chung-Hao Lin
BSBo-Yi Sung
Bo-Yi Sung
YCYi-Fang Chuang
Yi-Fang Chuang
JSJonathan P. Schneck
Jonathan P. Schneck
GWGeorge C. Wang
George C. Wang
Cytomegalovirus (CMV) infection is one of the most common persistent viral infections in humans worldwide and is epidemiologically associated with many adverse health consequences during aging. Previous studies yielded conflicting results regarding whether large, CMV-specific T-cell expansions maintain their function during human aging. In the current study, we examined the in vitro CMV-pp65-reactive T-cell response by comprehensively studying five effector functions (i.e., interleukin-2, tumor necrosis factor-α, interferon-γ, perforin and CD107a expression) in 76 seropositive individuals aged 70 years or older. Two data-driven, polyfunctionality panels (IL-2-associated and cytotoxicity-associated) derived from effector function co-expression patterns were used to analyze the results. We found that, CMV-pp65-reactive CD8 + and CD4 + T cells contained similar polyfunctional subsets and the level of polyfunctionality was related to the size of antigen-specific response. In both CD8 + and CD4 + cells, polyfunctional cells with high cytotoxic potential accounted for a larger proportion of the total response as the total response size increased. Notably, a higher serum CMV-IgG level was positively associated with a larger T-cell response size and a higher level of cytotoxic polyfunctionality. These findings indicate that CMV-pp65-specific CD4 + and CD8 + T cell undergo simultaneous cytotoxic polyfunctionality maturation during aging.

28 October 2011 in Immunity & Ageing
Verified
Journal Article
Open access
PDF file
Mark R. WillsMark R. Wills
Mark R. Wills
AAArne Akbar
Arne Akbar
MBMark Beswick
Mark Beswick
JBJos A Bosch
Jos A Bosch
Calogero CarusoCalogero Caruso
Calogero Caruso
Graham PawelecGraham Pawelec
Graham Pawelec
The Second International Workshop on CMV & Immunosenescence was held in Cambridge, UK, 2-4th December, 2010. The presentations covered four separate sessions: cytomegalovirus and T cell phenotypes; T cell memory frequency, inflation and immunosenescence; cytomegalovirus in aging, mortality and disease states; and the immunobiology of cytomegalovirus-specific T cells and effects of the virus on vaccination. This commentary summarizes the major findings of these presentations and references subsequently published work from the presenter laboratory where appropriate and draws together major themes that were subsequently discussed along with new areas of interest that were highlighted by this discussion.